Inventor · disambiguated record
Han-Qing Dong
Also filed as: DONG HAN · DONG HAN-QING
11 granted patents·5 pending applications·140 citations·filing 2004–2024
90Inventor score
Files withOSI PHARM INC10CHEN XIN2DANA FARBER CANCER INST INC2DONG HAN-QING1MASSACHUSETTS INST TECHNOLOGY1
Top patents by PatentIndex Score
16 records- 0195US7700594B2Fused bicyclic mTOR inhibitorsOSI PHARM INC·Filed 2006·Granted Apr 20, 2010·38 cites·6 claims
- 0289US8314111B2Fused bicyclic motor inhibitorsCHEN XIN·Filed 2011·Granted Nov 20, 2012·12 cites·2 claims
- 0389US7648987B2Bicyclic protein kinase inhibitorsOSI PHARM INC·Filed 2006·Granted Jan 19, 2010·17 cites·8 claims
- 0488US7943767B2Fused bicyclic mTOR inhibitorsOSI PHARM INC·Filed 2009·Granted May 17, 2011·9 cites·14 claims
- 0588US7459554B2Imidazopyrazine tyrosine kinase inhibitorsOSI PHARM INC·Filed 2004·Granted Dec 2, 2008·45 cites·68 claims
- 0687US8796455B2Fused bicyclic mTOR inhibitorsCHEN XIN·Filed 2013·Granted Aug 5, 2014·8 cites·10 claims
- 0778US2025206791A1Use of ire1alpha-xbp1 signaling pathway biomarkers for modulating immune responsesDANA FARBER CANCER INST INC·Filed 2024·Application pending·0 cites
- 0874US7521448B2N-substituted benzimidazolyl c-Kit inhibitorsOSI PHARM INC·Filed 2004·Granted Apr 21, 2009·9 cites·6 claims
- 0965US12227548B2Use of IRE1α-XBP1 signaling pathway biomarkers for modulating immune responsesDANA FARBER CANCER INST INC·Filed 2019·Granted Feb 18, 2025·0 cites·12 claims
- 1064US7442709B2N3-substituted imidazopyridine c-Kit inhibitorsOSI PHARM INC·Filed 2004·Granted Oct 28, 2008·2 cites·4 claims
- 1163US7767673B2N-substituted imidazopyridine c-Kit inhibitorsOSI PHARM INC·Filed 2008·Granted Aug 3, 2010·0 cites·8 claims
- 1257US2011190496A1FUSED BICYCLIC mTOR INHIBITORSOSI PHARM INC·Filed 2011·Application pending·0 cites
- 1353US2009181940A1Imidazopyrazine Tyrosine Kinase InhibitorsOSI PHARM INC·Filed 2008·Application pending·0 cites
- 1449US7498354B2Pyrrolo[2,3-D]imidazoles for the treatment of hyperproliferative disordersOSI PHARM INC·Filed 2006·Granted Mar 3, 2009·0 cites·13 claims
- 1546US2023149460A1Methods for generating engineered memory-like nk cells and compositions thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Application pending·0 cites
- 1646US2007129364A1Pyrrolopyridine kinase inhibiting compoundsDONG HAN-QING·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Han-Qing Dong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →